Liberation reinforces drug profits by 210% on an annual basis
Listen to the article Karachi: Due to the liberalized prices, the Pakistani pharmaceutical sector observed a significant increase in profitability, publishing 210% on an annual basis (YOY) an increase in RS13.5 billion in the calendar year 2024, according to data compiled by Arif Habib Limited (AHL). The net revenue of the sector increased by 21.1% on a yearly basis, reaching 196.8 billion Rs, with top contributions from AGP (+33.8% on an annual basis), Glaxo (+23.2% annual “This 210% increase (or 3.1 times) annual years is due to higher volumes of sales and prices after releasing drug prices,” said AHL Menka








